首页> 美国卫生研究院文献>BMC Public Health >The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
【2h】

The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial

机译:伐尼克兰联合尼古丁电子烟对精神疾病和成瘾者戒烟的有效性和安全性:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSmoking rates are higher in New Zealand (NZ) adults with mental illnesses and alcohol and other drug (AOD) addictions, compared to the overall population. Quit attempts using “gold standard” smoking cessation treatments often fail in people with these conditions, so more flexible treatment regimens that adapt to a person’s responsiveness to treatment are worth investigating. The STATUS trial aims to evaluate the effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation among varenicline non-responders in treatment for mental health illnesses and/or AOD addictions.
机译:背景与整体人口相比,患有精神疾病和酒精及其他药物(AOD)成瘾的新西兰成年人的吸烟率更高。在这种情况下,使用“黄金标准”戒烟疗法戒烟的尝试通常会失败,因此,更灵活的治疗方案可以适应一个人对治疗的反应,因此值得进行研究。 STATUS试验旨在评估伐尼克兰无烟者在治疗精神健康疾病和/或AOD成瘾时,联合使用伐尼克兰和尼古丁电子烟对戒烟的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号